Meroven Pharma India Private Limited
About Meroven Pharma India Private Limited
Data last updated:
Meroven Pharma India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Meroven For General Trading And Contracting. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2016FTC304106.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Eyad A S A Alsaleh and Alaa E A S A Alsaleh.
Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 708 Surya Kiran Building 19 Kasturba Gandhi Marg, New Delhi, Delhi, India – 110001.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Meroven Pharma India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address708 Surya Kiran Building 19 Kasturba Gandhi Marg, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Meroven Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meroven Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Meroven Pharma India Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Meroven Pharma India Private Limited, buy the company report.
Board of directors of Meroven Pharma India Private Limited
Meroven Pharma India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Eyad A S A Alsaleh | Director | 08 Aug 2016 | 10 Years 3 Months | Current |
| Alaa E A S A Alsaleh | Director | 08 Aug 2016 | 10 Years 3 Months | Current |
| Abdalla Rafik Darvesh | Additional Director | 10 Apr 2018 | 8 Years 7 Months | Current |
Auditor
Meroven Pharma India Private Limited is audited by J P K A D & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J P K A D & ASSOCIATES | FY 2020 | 015241S |
Shareholding
The shareholding of Meroven Pharma India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Meroven Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meroven Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meroven Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Meroven Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Meroven Pharma India Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Balasubramanian Ramanand ceased to be Director on 11 Apr 2018.
Frequently asked questions
Meroven Pharma India is an active foreign private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2016 (10+ years old) and is registered under CIN U24299DL2016FTC304106.
Meroven Pharma India has 3 current directors:
- Eyad A S A Alsaleh - Director
- Alaa E A S A Alsaleh - Director
- Abdalla Rafik Darvesh - Additional Director
The latest financial statements of Meroven Pharma India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 December 2020. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Meroven Pharma India is U24299DL2016FTC304106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meroven Pharma India was incorporated on 08 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Balasubramanian Ramanand ceased to be Director on 11 Apr 2018. Abdalla Rafik Darvesh was appointed as Additional Director on 10 Apr 2018. Alaa E A S A Alsaleh was appointed as Director on 08 Aug 2016. Meroven Pharma India has 4 board changes on record in total.
The registered office of Meroven Pharma India is at 708 Surya Kiran Building 19 Kasturba Gandhi Marg, New Delhi, Delhi, India – 110001.
Meroven Pharma India operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Meroven Pharma India is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Meroven Pharma India can be reached at its registered office: 708 Surya Kiran Building 19 Kasturba Gandhi Marg, New Delhi, Delhi, India – 110001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
